Improving the Health of Humankind
Ajinomoto Co., Inc’s involvement with medicine shouldn’t be all that surprising. Amino acids are at the heart of molecular medicine and science, and we began producing amino acid derivatives for therapeutic use more than 30 years ago. But making a strong contribution in today’s revolutionary approaches to medicine requires an extraordinary level of expertise, technology, and dedication.
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a contract development and maufacturing organization for the biopharmaceutical industry, represents all of these things. Aji Bio-Pharma creates and produces medicines across the entire spectrum of use, from pre-clinical development of the molecules themselves in the pre-clinical phase, to small-scale production in clinical trials, to full production for all people in need once the medicine has been tested and approved.
AJICAP™: On the Cutting Edge of Cancer Treatment
One of the most exciting cutting-edge technologies being offered by Ajinomoto Co. and Aji Bio-Pharma is called AJICAP™.
To understand AJICAP™, you ﬁrst must understand a bit about “biological medicines,” and why they are becoming such a common treatment approach for people with cancer.
It’s useful to think of a disease as an invasion by something that your body didn’t make. For example, if you have a cut that is invaded by bacteria, you can get an infection, or if a virus invades your sinuses, you can get a head cold. For these types of conditions, the objective of treatment is to remove or neutralize the foreign invader. In the case of bacteria, for example, this means using antibiotics.